Gerry Smith

Vertex Pharmaceuticals Inc. sued the US government for permission to pay for fertility treatment for people who get a gene therapy made by the company that can interfere with reproduction.

Hi, it’s Gerry in New York, where I’ve talked to parents weighing the pros and cons of a drug to treat a devastating muscle disease. But first ...

Hi, it's Gerry in New York, where I've talked to parents weighing the pros and cons of a drug to treat a devastating muscle disease. But first ...

Cassava Sciences Inc. shares plunged after its chief executive officer resigned, the latest turmoil at the biotech company being investigated by US watchdogs.

Despite their dismal reputation, the aging painkillers are cheap and work better than nonaddictive replacements.

Pfizer Inc.’s gene therapy for a severe bleeding disorder met its goal in a pivotal late-stage trial, paving the way for the company to enter what’s proven to be a challenging market for drug companies.

Pfizer Inc. 's gene therapy for a severe bleeding disorder met its goal in a pivotal late-stage trial, paving the way for the company to enter what's proven to be a challenging market for drug companies.

Sage Therapeutics Inc. plunged after a mid-stage study of its drug to treat essential tremor failed, dealing another blow to the company’s pipeline.

European drug regulators rejected an Alzheimer's drug from Eisai Co. and Biogen Inc. , a blow to the companies seeking to expand sales in one of the world's biggest drug markets.

European drug regulators rejected an Alzheimer’s drug from Eisai Co. and Biogen Inc., a blow to the companies seeking to expand sales in one of the world’s biggest drug markets.